Home/Pipeline/Anti-tumor Class

Anti-tumor Class

Various Cancers

Not specified (API/Formulation)Commercial/Development

Key Facts

Indication

Various Cancers

Phase

Not specified (API/Formulation)

Status

Commercial/Development

Company

Ausun Pharm

About Ausun Pharm

A publicly traded Chinese pharmaceutical company specializing in complex small molecule and peptide APIs, formulations, and CDMO services for global markets.

View full company profile

Therapeutic Areas

Oncology Immunology Metabolic Diseases Cardiovascular Infectious Disease

Other Various Cancers Drugs

Drug	Company	Phase	Status
Oncology/Immuno-oncology Portfolio	MSD	Phase III/Commercial	Active
Bevacizumab Biosimilar	Dr. Reddy's Laboratories	Approved	Launched in UK
LADR Platform	LadRx	Preclinical	Research
NK Cell Stimulation (via JadiCell)	Therapeutic Solutions International	Preclinical	Research
Zip-Code Library for Oncology	Kodikaz Therapeutic Solutions	Pre-clinical	Active
Proprietary RLT Pipeline	Affibody	Not Specified (Preclinical-Phase 2)	Active
Preclinical ASO Portfolio	Isarna Therapeutics	Preclinical	Active
SPACE-GM Microenvironment Analysis	Enable Medicine	Research	Active
Oncology Program(s)	CIS Pharma	Pre-clinical	Active
Max Access Solutions (with The Max Foundation)	Tanner Pharma Group	N/A (Donation/Distribution Program)	Active
CPA Platform in Oncology	InnoSIGN	Development	Active
Oncology Services	Transcure Bioservices	Preclinical	Active